Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Circulation|November 1, 1985
Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapyP C Adams, D W Holt, G C Storey, et al.
International Journal of Laboratory Hematology|August 27, 2009
Relationships of serum free thyroxine and erythrocyte measures in euthyroid HFE C282Y homozygotes and control subjects: the HEIRS studyJ C Barton, C Leiendecker-Foster, D M Reboussin, et al.
Transfusion|June 23, 1999
A survey of phlebotomy among persons with hemochromatosisS M McDonnell, A J Grindon, B L Preston, et al.
British Heart Journal|December 1, 1995
Prospective study of patients aged 55 years or less with acute myocardial infarction between 1981 and 1985: outcome 7 years and beyondJ S Skinner, C J Albers, J Goudevenos, et al.
European Heart Journal|September 1, 1994
Prospective evaluation of a prostacyclin-sparing aspirin formulation and heparin/warfarin in aspirin users with unstable angina or non-Q wave myocardial infarction at rest. The Antithrombotic Therapy in Acute Coronary Syndromes Research GroupM Cohen, G Parry, P C Adams, et al.
Drugs|January 1, 1987
The effect of thrombolytic therapy with anisoylated plasminogen streptokinase activator complex on the indicators of myocardial salvageM B Buchalter, J P Bourke, K Jennings, et al.
The American Journal of Medicine|June 23, 1999
A survey of 2,851 patients with hemochromatosis: symptoms and response to treatmentS M McDonnell, B L Preston, S A Jewell, et al.
Heart (British Cardiac Society)|July 16, 2003
A prospective study of long term prognosis in young myocardial infarction survivors: the prognostic value of angiography and exercise testingA A Awad-Elkarim, J P Bagger, C J Albers, et al.
The Quarterly Journal of Medicine|May 1, 1986
Amiodarone pulmonary toxicity: clinical and subclinical featuresP C Adams, G J Gibson, A R Morley, et al.
BMJ (Clinical Research Ed.)|October 2, 1993
Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart diseaseM Farrer, F L Game, C J Albers, et al.
Pageof 18